» Articles » PMID: 28173800

Oxidized LDL-induced JAB1 Influences NF-κB Independent Inflammatory Signaling in Human Macrophages During Foam Cell Formation

Overview
Journal J Biomed Sci
Publisher Biomed Central
Specialty Biology
Date 2017 Feb 9
PMID 28173800
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Oxidized low-density lipoprotein (oxLDL) mediates the transformation of macrophages (MΦ) to cholesterol-rich foam cells and the release of pro-inflammatory cytokines during atherogenesis. JAB1 (Jun activation domain binding protein-1) is present in all stages of human plaques, involved in the Toll-like receptor-mediated activation of p38 mitogen-activated protein kinase (MAPK) and controls nuclear factor-kappa B (NF-κB) activation. Thus, we were interested in the role of JAB1 during foam cell formation of MΦ after oxLDL exposition.

Methods And Results: We found that JAB1 was present in CD68-immunoreactive (-ir) MΦ in atherosclerotic plaques of apolipoprotein E knockout (ApoE) mice after a high cholesterol/fat diet. Furthermore, differentiated human U937 MΦ - incubated with oxLDL (4 h) to induce foam cell formation - showed a significant increase of JAB1 (50 μg/ml: 1.39 + 0.15-fold; 100 μg/ml: 1.80 + 0.26-fold; 200 μg/ml: 2.05 + 0.30-fold; p < 0.05) on the protein level compared to the control. Independent from JAB1 silencing, we found an increase of total cholesterol (TC), free cholesterol (FC) and cholesteryl ester (CE) after oxLDL exposition. However, siJAB1-MФ showed a reduction of tumor necrosis factor-alpha (TNF-α) (36%; p < 0.05 vs. non-transfected MФ) and interleukin (IL)-6 (30%; p < 0.05 vs. non-transfected MФ) mRNA expression, as well as TNF-α (46%; p < 0.05 vs. non-transfected MФ) and IL-6 (32%; p < 0.05 vs. non-transfected MФ) protein secretion after oxLDL exposition. In parallel with an upregulation of inflammatory cytokines (TNF-α, IL-6) after oxLDL exposition, we found a significant (p < 0.05) increase of 37% in p38 MAPK activation after 4 h oxLDL-treatment, independent from NF-kB signaling. In this context, we showed regional co-localization of JAB1 with p38 MAPK in atherosclerotic plaques of ApoE mice. Moreover, we detected interaction of JAB1 with p38 MAPK in U937 cells.

Conclusion: We demonstrate that oxLDL induces JAB1 expression and influences its cellular localization, whereby the p38 MAPK signaling pathway is modified with consequences for inflammation of human MΦ in foam cells and atherosclerotic lesions.

Citing Articles

Association between life's simple 7 (LS7) and arthritis: the mediating role of body fat percentage (BFP).

Chen H, Wang Z, Du N, Oh J, Xu J, Liu R Lipids Health Dis. 2024; 23(1):415.

PMID: 39707467 PMC: 11660577. DOI: 10.1186/s12944-024-02392-7.


Characterization of prostate macrophage heterogeneity, foam cell markers, and CXCL17 upregulation in a mouse model of steroid hormone imbalance.

Silver S, Tucker K, Vickman R, Lanman N, John Semmes O, Alvarez N Sci Rep. 2024; 14(1):21029.

PMID: 39251671 PMC: 11383972. DOI: 10.1038/s41598-024-71137-4.


Research progress of SREBP and its role in the pathogenesis of autoimmune rheumatic diseases.

Xu X, Jin W, Chang R, Ding X Front Immunol. 2024; 15:1398921.

PMID: 39224584 PMC: 11366632. DOI: 10.3389/fimmu.2024.1398921.


PROSTATE CELL HETEROGENEITY AND CXCL17 UPREGULATION IN MOUSE STEROID HORMONE IMBALANCE.

Silver S, Tucker K, Vickman R, Lanman N, John Semmes O, Alvarez N bioRxiv. 2024; .

PMID: 38712029 PMC: 11071464. DOI: 10.1101/2024.04.24.590980.


A novel alternative for pyrogen detection based on a transgenic cell line.

He Q, Yu C, Wu G, Wang K, Ni Y, Guo X Signal Transduct Target Ther. 2024; 9(1):33.

PMID: 38369543 PMC: 10874988. DOI: 10.1038/s41392-024-01744-0.


References
1.
Witztum J, Steinberg D . Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991; 88(6):1785-92. PMC: 295745. DOI: 10.1172/JCI115499. View

2.
Vindis C . Autophagy: an emerging therapeutic target in vascular diseases. Br J Pharmacol. 2014; 172(9):2167-78. PMC: 4403086. DOI: 10.1111/bph.13052. View

3.
Schweitzer K, Bozko P, Dubiel W, Naumann M . CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha. EMBO J. 2007; 26(6):1532-41. PMC: 1829370. DOI: 10.1038/sj.emboj.7601600. View

4.
Boncler M, Rozalski M, Krajewska U, Podsedek A, Watala C . Comparison of PrestoBlue and MTT assays of cellular viability in the assessment of anti-proliferative effects of plant extracts on human endothelial cells. J Pharmacol Toxicol Methods. 2013; 69(1):9-16. DOI: 10.1016/j.vascn.2013.09.003. View

5.
Karin M, Ben-Neriah Y . Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000; 18:621-63. DOI: 10.1146/annurev.immunol.18.1.621. View